Category: News

Terumo Invests in Quirem Medical, Focusing on Interventional Oncology Field

September 9th, 2015 – Terumo Corporation (Headquarters: Shibuya-ku, Tokyo, Japan; President: Yutaro Shintaku) and Quirem Medical B.V., a commercial stage Dutch medical technology company that focuses on radioembolization, today announced that Terumo has made an equity investment in Quirem Medical. Quirem Medical develops QuiremSpheres™, next generation microspheres for the radioembolization treatment

Read More »

New Liver Cancer Treatment Approved for Use in Europe

Quirem Medical receives CE mark – New Liver Cancer Treatment Approved for Use in Europe A new treatment for liver cancer developed by the University Medical Center (UMC) Utrecht has received the European CE mark for quality and safety. This implies that hospitals throughout Europe can now start using this

Read More »

Quirem Medical on YouTube

The unique image guidance capabilities of QuiremSpheres® are covered in a recent video of the University Medical Centre Utrecht. Click on the link to watch the video.

Read More »

Therapy with Holmium microspheres now also used for head and neck tumors

Researchers at UMC Utrecht are developing an innovative cancer treatment with the help of a grant from Alpe d’HuZes/Dutch Cancer Society (KWF) of nearly 300,000 euros. The treatment involves the injection of radioactive beads into tumors, thereby enabling a very precise localized radiotherapy. Direct injection of radioactive beads may be

Read More »

Quirem Medical in the news, November 4th 2014

Holmium microspheres and Quirem Medical feature in the latest publication of Interventional News that covers Holmium microspheres as having the potential to become The Next Generation Microspheres for Radioembolization. Read all about it in this article.

Read More »

CIRSE 2014 Excellence and Innovation Award for UMCU

The Quirem Medical team congratulates the University Medical Centre Utrecht with winning the CIRSE 2014 Excellence and Innovation Award in Interventional Radiology. This prestigious prize has been awarded to the Holmium research team from the UMCU for their innovative work in developing Holmium-166 microspheres, the first radioactive microspheres that can

Read More »

Collaboration UMC Utrecht and Quirem Medical on Holmium Microspheres

The coming years, the University Medical Center (UMC) Utrecht and Quirem Medical will be working closely together to maximize the benefits of using holmium microspheres to treat liver cancer patients worldwide. The unique properties of holmium microspheres will enable effective treatment planning, dosimetry and treatment evaluation, thereby further improving the

Read More »

Available: Essay on the Future of Radioembolization

As part of our Holmium, the Future of Radioembolization initiative we are pleased to offer interested readers the possibility to obtain a copy of the essay: Holmium Radioembolization of Liver Metastases from Maarten Smits that was published in December 2013 and includes the Lancet Oncology article on the successful first

Read More »

Holmium Microspheres, the Future of Radioembolization

Quirem Medical was proud to be the main sponsor of the symposium Holmium Microspheres, the Future of Radioembolization on December 18, 2013 in Utrecht, The Netherlands. For further information on the materials presented and discussed during this symposium please use the contact page.

Read More »

Winner of the BioBusiness Masterclass 2013

Quirem Medical is the winner of the BioBusiness Masterclass 2013!. The final took take place on December 9 2013 during the Dutch Life Sciences Conference 2013 (http://www.dutchlifesciences.com/) in Oss, The Netherlands.

Read More »